Mirae Asset Global Investments Co. Ltd. decreased its position in shares of Invitae Co. (NYSE:NVTA – Get Rating) by 21.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,415,682 shares of the medical research company’s stock after selling 391,747 shares during the period. […]
StockNews.com initiated coverage on shares of Invitae (NYSE:NVTA – Get Rating) in a research note issued to investors on Thursday morning. The brokerage issued a sell rating on the medical research company’s stock. Several other research analysts also recently issued reports on NVTA. The Goldman Sachs Group downgraded shares of Invitae from a neutral rating […]
Invitae Co. (NYSE:NVTA – Get Rating) CEO Kenneth D. Knight sold 45,432 shares of the stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $1.20, for a total transaction of $54,518.40. Following the completion of the transaction, the chief executive officer now owns 1,671,610 shares of the […]
Stock analysts at StockNews.com assumed coverage on shares of Invitae (NYSE:NVTA – Get Rating) in a research note issued on Thursday. The firm set a “sell” rating on the medical research company’s stock. A number of other research analysts also recently commented on the company. The Goldman Sachs Group downgraded Invitae from a “neutral” rating […]
Raymond James downgraded shares of Invitae (NYSE:NVTA – Get Rating) from a market perform rating to an underperform rating in a report issued on Monday morning, The Fly reports. A number of other equities analysts also recently commented on NVTA. Piper Sandler reduced their price objective on shares of Invitae from $2.25 to $1.75 and […]